Remember that big Avandia safety analysis that showed up in the New England Journal of Medicine last year suggesting the drug raised heart attack risk? Turns out, somebody at GlaxoSmithKline knew ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback